Stock market announcement archive

LIFE: Innkalling til Generalforsamling i Lifecare AS

April 23, 2021
Lifecare AS avholder Generalforsamling 7. mai 2021 kl 10:00. Møtet vil bligjennomført som et kombinert fysisk og digitalt møte. Aksjonærer oppfordres tilå delta digitalt eller å forhåndsstemme via den elektroniske plattformen. Nærmere informasjon om deltakelse og påmelding fremkommer av innkallingen. Innkalling og årsberetning følger vedlagt denne meldingen. Generalforsamlingenssaksdokumenter kan lastes ned fra www.lifecare.attme.dev/GF2020. Kontaktperson: Joacim […]
Read more

LIFE: Lifecare well protected in the event of Digid bankrupcy

April 4, 2021
4. April 2021, Bergen - Digital Diagnostics AG's (Digid) management has filedfor bankruptcy at the district court of Mainz. The filing was delivered withoutany prior information to or discussion with the Digid Supervisory board. The joint venture agreement regarding Digid provides protection of Lifecare'sinterests, including Lifecare IP rights, in the event of a bankruptcy. "All […]
Read more

LIFE: The European Patent Office intends to issue new Lifecare patent

March 25, 2021
25 March 2021, Bergen - Today, Lifecare announces that The European PatentOffice has issued its intent to grant Lifecare a new patent, expandingLifecare's patent protection in time and scope. Lifecare has reviewed theexamining division's comments to the patent application and concludes that thesuggested cosmetic changes are acceptable. On this base, Lifecare expects theEuropean Patent Office […]
Read more

LIFE: Lifecare AS (LIFE) Digid Cantisense Update

March 19, 2021
March 19th, 2021, Bergen - Lifecare's partner, Digital Diagnostics AG (Digid),has developed a novel 5-minute antigen rapid virus detection test. TheCantisense test method is based on proteins binding onto the virus antigen,which leads to electronically measurable changes. The method is highlysophisticated and advanced compared to already existing virus detection testmethods: - The monoclonal antibody technology […]
Read more

LIFE: Lifecare (Life) recieves regulatory approval for first-in-human Clinical Pilot Evaluation

February 15, 2021
Bergen, February 15th, 2021 - Lifecare AS (LIFE) Lifecare has received regulatory approval for the first-in-human SencellClinical Study Protocol from the German Federal Institute for Drugs and MedicalDevices (BfArM). With this final remaining approval, Lifecare has reached itsgoal to have clinical pilot trial permission as planned in Q1 2021. Lifecare CEO Joacim Holter says, "With […]
Read more

LIFE: Finansiell kalender

February 15, 2021
Finansiell kalender for Lifecare ASREGNSKAPSÅR 202105.08.2021 - Halvårsrapport20.04.2021 - Årsrapport07.05.2021 - Ordinær generalforsamlingDenne informasjonen offentliggjøres i henhold til kravene i Løpendeforpliktelser.
Read more

LIFE: Financial calendar

February 15, 2021
Financial calendar for Lifecare ASFINANCIAL YEAR 202105.08.2021 - Half-yearly Report20.04.2021 - Annual Report07.05.2021 - Annual General MeetingThis information is published pursuant to the requirements set out in theContinuing obligations.
Read more

Regarding Share Transfere AGreement Human Data – Evergreen 20.10.20

October 20, 2020
Stock Market announcement Bergen, Norway – October 20, 2020: The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in the German company Digital Diagnostics AG, which has developed an accurate and reliable rapid test for Covid-19. Bionovate Technologies Corp. (BIIO), a swiss based company traded at Nasdaq OTC Foreign, has announced a Share […]
Read more

Vedr aksjebytte avtale Human Data – Evergreen 20.10.20

October 20, 2020
Bergen – 20. oktober 2020: Lifecare AS (LIFE-ME) eier 25% av Digital Diagnostics AG, som har utviklet en hurtigtest for Covid-19. Bionovate Technologies Corp. (BIIO), et sveitsisk basert selskap notert som Nasdaq OTC Foreign, har annonsert aksjebytteavtale mellom Evergreen Solutions Ltd. og Human Data AG til United States Securities and Exchange Commission. Aksjebytteavtalen omfatter ifølge […]
Read more

Lifecare – klargjøring vedr kjerneteknologi – 13.10.20

October 13, 2020
Som følge av verdifall for Lifecares (LIFE-ME) aksjer på Oslo Børs/Merkur Market mandag 12. oktober 2020 har selskapet mottatt spørsmål fra en rekke aksjonerer og ønsker å formidle følgende: Det er ingen endringer knyttet til Lifecares patenterte sensorteknologi, Sencell, verken alene eller knyttet til samarbeid med våre partnere Digital Diagnostics AG eller prosjektet FORGETDIABETES. Den […]
Read more